01—Abstract
Summary
Summary of the 8-K filed August 7, 2025. Cited figures are marked; the original filing is the authoritative source.
Constellation Energy (CEG) reported second-quarter 2025 results on August 7, 2025, with GAAP net income of $839 milliona, or $2.67 per diluted share, up from $2.58 a year earlier, and Adjusted (non-GAAP) Operating Earnings of $599 million, or $1.91 per share, up from $1.68.
The increase was driven by higher revenue recognition from banked Illinois ZEC credits and favorable market and portfolio conditions, partly offset by lower nuclear production tax credits (PTCs) due to higher projected gross receipts. Management reaffirmed full-year 2025 Adjusted Operating Earnings guidance of $8.90b-$9.60 per share. GAAP results were flattered by a $440 million 'Other, net' line in the quarter, which the company adjusts out of its non-GAAP measure, so investors should weigh the GAAP-to-adjusted bridge carefully.
Six-month GAAP net income fell to $957 millionc from $1,697 million a year earlier, largely reflecting unrealized fair-value swings. The quarter's operational and strategic news centered on a 20-year power purchase agreement with Meta for the full output of the Clinton Clean Energy Center, starting June 2027, with an expected 30 MW uprate. The company also accelerated the Crane Clean Energy Center (formerly Three Mile Island Unit 1) restart into 2027, and the Calpine acquisition received FERC, New York PSC, and Texas PUCT approvals, with closing still targeted for the fourth quarter of 2025.
The company described the deal as accretive to Adjusted Operating Earnings by more than 20% in 2026 and by at least $2.00d per share through 2029. Capital returns continued through a roughly $400 million accelerated share repurchase, and the dividend is planned to grow 10% in 2025.
Investors should note that the filing is furnished rather than filed, and that a large share of projected earnings depends on nuclear PTCs, Illinois ZEC and CMC payments, and PJM capacity prices. The Calpine transaction also carries integration and financing risks that the forward-looking statements flag, and the filing's leverage and rating commentary (Baa1 and BBB+, stable outlooks) is important for judging credit capacity during the deal.
02—Key points
Key Highlights
- GAAP EPS of $2.67 (net income $839M) vs. $2.58 in Q2 2024; Adjusted Operating EPS of $1.91 vs. $1.68, up about 14%
- Full-year 2025 Adjusted Operating Earnings guidance reaffirmed at $8.90-$9.60 per share, with base earnings of $6.70-$6.80
- 20-year Meta PPA for full output of Clinton Clean Energy Center, beginning June 2027, with a 30 MW uprate
- Calpine acquisition cleared FERC, New York PSC, and Texas PUCT; expected to close in Q4 2025, with management projecting more than 20% accretion in 2026
- Crane Clean Energy Center restart accelerated to 2027, ahead of the original schedule
- Roughly $400M accelerated share repurchase executed in Q2; about $600M remains under the $3.0B authorization
- Q2 nuclear capacity factor (ex-Salem/STP) of 94.8%, versus 95.4% a year earlier; 45,170 GWh generated, roughly flat year over year
03—Questions
Frequently Asked Questions
Why did Adjusted Operating EPS rise while GAAP EPS only modestly increased?
Adjusted Operating EPS rose to $1.91 from $1.68, driven by higher banked Illinois ZEC revenue recognition and favorable market and portfolio conditions, partly offset by lower nuclear PTCs. GAAP net income was affected by large unrealized fair-value gains (about $121M after tax, plus $144M from decommissioning-related items) and other items the company excludes from its non-GAAP measure. The bridge between the two measures is detailed in the filing's reconciliation table.
What is the status of the Calpine acquisition and what does it mean for investors?
The transaction has received FERC, New York PSC, and Texas PUCT approvals, and the company expects closing in Q4 2025. Management projects it will be accretive to Adjusted Operating EPS by more than 20% in 2026 and by at least $2.00 per share through 2029, and adds more than $2B of annual free cash flow before growth. Investors should watch the financing plan and the combined company's leverage, since the filing emphasizes maintaining an investment-grade balance sheet.
How significant is the Meta agreement and the Crane restart to long-term earnings?
The 20-year Meta PPA for Clinton's full output supports relicensing and extends the plant's operations for roughly two more decades, with deliveries starting June 2027. The Crane restart, moved up to 2027, adds clean firm capacity for PJM and supports expected generation growth in 2028 and beyond, with about 3 TWh in 2028 and 6 TWh in 2029 in the company's modeling. Both are long-term contracted or regulated revenue drivers rather than near-term earnings events.
Does the company's guidance depend on policy support such as the nuclear PTC?
Yes. Management's modeling shows that the nuclear PTC, which is up to $15/MWh and phases out between $26 and $44.75/MWh of gross receipts, plays a significant role in supporting revenue when market prices fall. The One Big Beautiful Bill Act preserved the 45U and 45Y nuclear credits, and the company expects an additional 10% bonus for nuclear energy communities. Changes in market prices or policy could shift the PTC's value, so investors should track the inflation adjustment and the gross receipts thresholds.
What are the key capital allocation priorities and balance sheet considerations?
The company completed a roughly $400M accelerated share repurchase and plans to deliver the remaining shares in Q3 2025, with about $600M left under the $3.0B program. It is also raising the dividend 10% in 2025. Bonus depreciation and immediate R&E expensing are expected to provide $200-$300M of annual cash benefit. Ratings are Baa1 (Moody's) and BBB+ (S&P), both with stable outlooks, affirmed after the Calpine announcement. Investors should weigh these returns against the financing needs of the pending acquisition.
04—Continue